DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome

類似資料

• Dosage of the Abcg1-U2af1 Region Modifies Locomotor and Cognitive Deficits Observed in the Tc1 Mouse Model of Down Syndrome
  著者:: Marechal, Damien, 等
  出版事項: (2015)
• Dosage of the Abcg1-U2af1 region modifies locomotor and cognitive deficits observed in the Tc1 mouse model of Down syndrome.
  著者:: Damien Marechal, 等
  出版事項: (2015-01-01)
• Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome
  著者:: Lana-Elola, Eva, 等
  出版事項: (2024)
• Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
  著者:: Nguyen, Thu Lan, 等
  出版事項: (2018)
• DYRK1A, a Novel Determinant of the Methionine-Homocysteine Cycle in Different Mouse Models Overexpressing this Down-Syndrome-Associated Kinase
  著者:: Noll, Christophe, 等
  出版事項: (2009)